Filspari

Active Ingredient(s): Sparsentan
FDA Approved: * February 17, 2023
Pharm Company: * TRAVERE
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Filspari 200 mg Oral Tablet, Film Coated
NDC: 68974-200
Labeler:
Travere Therapeutics, Inc.
Filspari 400 mg Oral Tablet, Film Coated
NDC: 68974-400
Labeler:
Travere Therapeutics, Inc.